News and Insights
Mass Layoffs Continue Across the Biotech Sector. What Does This Mean for Pharma’s Future?
More than 175 biotech layoffs were announced in 2023, easily surpassing 2022’s number of 119. While this is not a new trend, the current trajectory is concerning, as it portends more difficult times ahead for the pharmaceutical industry–already in the midst of a major upheaval. It should also be another wake-up call to pharma executives: the old way of doing business needs to change–and urgently.Read More
Thank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.
Whether you need a new plan or a second opinion, Numerof has the insight you're looking for.